Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering Drug Licensing Division To Be Headed By Ex-Pharmacia Exec

Executive Summary

Ex-Pharmacia exec Michael DuBois will head Schering-Plough's newly formed product licensing division

You may also be interested in...



Schering Will Audit Compliance With Anti-Bribery Law Under SEC Settlement

Schering-Plough will retain an independent consultant to review its compliance with the Foreign Corrupt Practices Act as part of a $500,000 settlement with the Securities & Exchange Commission

Schering Will Audit Compliance With Anti-Bribery Law Under SEC Settlement

Schering-Plough will retain an independent consultant to review its compliance with the Foreign Corrupt Practices Act as part of a $500,000 settlement with the Securities & Exchange Commission

Amgen As Model For Corporate Governance: CEO Says Ignorance Is No Excuse

CEOs should not be permitted to argue that they are ignorant of ethical deviations within their companies, Amgen CEO Kevin Sharer declared Jan. 14 during the J.P. Morgan health care conference in San Francisco

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel